| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |